Sun Pharmaceutical Industries share news, announcements and annual reports
NSE: SUNPHARMABSE: 524715Pharmaceuticals & BiotechnologyLarge Cap
Sun Pharmaceutical Industries Limited · Formerly Sun Pharmaceuticals Industries · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994 on BSE, Feb 1995 on NSE
Last close ₹1,761.00up ₹3.50 (0.20%)BSE ₹1,762.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,757.50.
29 Oct: open ₹1,757.50, high ₹1,771.50, low ₹1,752.70
52-week range of traded prices to 29 Oct 2026
₹1,583.70Low, 29 Jan 2026₹2,046.90High, 31 Jul 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,22,523 Cr13th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.91%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 16.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,07,85459.5% delivered
Sun Pharmaceutical Industries record dates, bonuses and splits
23 filed, newest first.
Jan 2026
20 Jan · Corporate action
Jan 2025
16 Jan · Corporate action
Jun 2024
19 Jun · Corporate action
Jan 2024
15 Jan · Corporate action
Jul 2023
7 Jul · Corporate action
Jan 2023
31 Jan · Corporate action
Aug 2022
2 Aug · Corporate action
Jan 2022
31 Jan · Corporate action
Aug 2021
Jan 2021
29 Jan · Corporate action
Jul 2020
Feb 2020
6 Feb · Corporate action
Jun 2016
24 Jun · Corporate action
Aug 2014
13 Aug · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from September 13, 2014 to September 27, 2014 (both days inclusive) for the purpose of payment of dividend and for holding of Annual General Meeting.
Aug 2013
13 Aug · Corporate action
Company has fixed Book Closure from September 23, 2013 to September 30, 2013 (both days inclusive) for the purpose of the Annual General Meeting of the Company and for the payment of dividend.
Jul 2013
19 Jul · Corporate action
Company has fixed Record Date as July 30, 2013 in order to determine the names of Members who are entitled to receive Bonus Equity shares in the ratio of 1:1 (i.e. one equity share of Re.1 each for every equity share of Re.1 each held by the shareholders).
May 2013
28 May · Corporate action
Board of Directors of the Company at its meeting held on May 28, 2013 has recommended the issue of Bonus Equity shares of Re.1 each subject to the receipt of approval of the equity shareholders of the Company, to the equity shareholders of the Company in the ratio of 1(one) equity share for every 1 (one) no. of equity shares held by equity shareholders in the Company, as on the record date to be fixed by the Board after receiving approval from the shareholders for issue of such bonus shares.
Aug 2012
6 Aug · Corporate action
Board has fixed the record date of August 16, 2012 for the purpose of payment of interim dividend for the year ended 31st March, 2012 in lieu of the earlier recommended proposed dividend for the year ended March 31, 2012 if such proposed interim dividend is declared at the ensuing Board Meeting. Further if interim dividend is declared by the Board ,it would be paid on or after August 22, 2012.
Nov 2010
15 Nov · Corporate action
Company has fixed November 26, 2010 as the Record Date for the purpose of ascertaining the names of the shareholders who would be entitled to receive 5 (five) equity shares of the nominal face value of Re.1 each for every 1 (one) equity of Rs.5 each held by them.
Aug 2010
11 Aug · Corporate action
Register of the Company will be closed from September 14, 2010 to September 24, 2010 (both days inclusive) for the purpose of payment of dividend for the year ended March 31, 2010.
May 2009
30 May · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from August 25, 2009 to September 05, 2009 (both days inclusive) for the purpose of payment of dividend.
Sep 2007
11 Sep · Corporate action
Company has fixed October 12, 2007 as the Record Date for the purpose of reckoning the names of the Preference Shareholders of Sun Pharmaceuticals Industries Ltd. (SPIL) who shall be entitled to receive the redemption proceeds of preference shares of Re.1/- each at par value on the due date of redemption on November 1, 2007 and thereafter no transfers could be effected/valid. Further the Company has decided to redeem the outstanding Preference Shares of Re.1/- each at par value without calling for preference share certificates in physical form or without asking for credit to specified account for redemption in case of preference shares in de-mat form.